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Introduction
Klebsiella pneumoniae is an opportunistic pathogen 
of the Enterobacteriaceae family and principally causes 
pneumonia (Podschun and Ullmann, 1998), and also is 
associated with pyogenic liver abscesses over the past 
decade (Wang et al., 1998) and it has been implicated 
in 7–12% of hospital-acquired pneumonia in ICUs in 
the United States (1997). It typically expresses different 
virulence factor genes such as a smooth lipopolysac-
charide (O antigen) and capsule polysaccharide (K anti-
gen) on its surface (Kenne et al., 1983). There are at least 
77  capsular serotypes defined, and serotype-related 
variation in the infection severity has been observed. 
Out of 77 capsular serotypes (K), the strains with cap-
sular serotypes K1 and K2 have been identified as the 
predominant virulent strains, and their virulence has 
been confirmed in mouse models (Fung et al., 2002). 
The rmpA is a transcriptional activator of capsular 
polysaccharide (CPS) gene transcription, CPS synthesis 
and HV in K. pneumoniae K1/K2 (Lai et al., 2003). The 
uge gene encodes uridine diphosphate galacturonate 
4-epimerase which expresses both smooth lipopoly-
saccharide with O antigen molecules and CPS with 
K antigen on the surface. Aerobactin is a siderophore 
that aids the bacterium in its competition with the host 
for iron (Quinn, 1994). The kfu gene encodes for an 
iron uptake system which is a significantly associated 
with the purulent tissue infections and HV phenotype 
(Ma et al., 2005). The fimH (or fimH-1) and mrkD 
genes which are relevant to type 1 and type 3 fimbriae 
respectively are responsible for attachment to host cells 
(Podschun and Ullmann, 1998). These all factors con-
tribute to virulence and are important for colonization, 
invasion and pathogenicity. 
K. pneumoniae strains usually recognized by micro-
biologists and clinicians are termed as cKP. Such strains 
are scandalous for their capability to cause acquired 
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A b s t r a c t
Klebsiella pneumoniae strains that are commonly recognized by clinicians and microbiologists are termed as classical K. pneumoniae (cKP). 
A strain with capsule-associated mucopolysaccharide web is known as hypervirulent K. pneumoniae (hvKP) as it enhances the serum 
resistant and biofilm production. Aim is to determine and correlate various virulence genes, ESBL, serum bactericidal effect and biofilm 
formation of clinical isolated cKP and hvKP from respiratory tract infected patients. A total of 96 K. pneumoniae strains were isolated from 
sputum of respiratory tract infected patients. The isolates were performed string test, AST, ESBL virulence gene, serum bactericidal and 
biofilm assays. Out of 96 isolates, 39 isolates (40.6%) were identified with hypervirulent phenotypes. The number of cKP exhibiting resist-
ance to the tested antimicrobials and ESBLs were significantly higher than that of the hvKP strains. The virulence genes of K. pneumoniae 
such as K1, K2, rmpA, uge, kfu and aerobactin were strongly associated with hvKP than cKP. However, no significant difference was found 
in FIM-1 and MrKD3 genes. ESBL producing cKP and hvKP were significantly associated with strong biofilm formation (both P < 0.05) 
and highly associated with bactericidal effect of serum (both P < 0.05) than cKP strains. However, neither biofilm formation nor bactericidal 
effect of serum was found with significant difference in between ESBL producing cKP and ESBL producing hvKP strains (both P > 0.05). 
Although the hvKP possess more virulence gene, but they didn’t show any significant difference between biofilm formation and bactericidal 
effect of serum compared with ESBL producing cKP strains.
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hospital infections and acquire multidrug resistant 
especially extended-spectrum beta lactamase (ESBL) 
that has led the treatment to limited options (Ko et al., 
2002; Podschun and Ullmann, 1998). ESBLs are plas-
mid mediated enzymes and it inactivate β-lactam 
antibiotics such as oxyimino-cephalosporins and oxy-
imino-monobactam, except cephamycins and carbap-
enems (Paterson and Bonomo, 2005) and it is inhibited 
by clavulanic acid and placed it under Bush’s functional 
class 2be (Bush et al., 1995). Till the date more than 
200 different types of ESBLs have been found. There is 
a increase in the prevalence of TEM, SHV and CTX-M 
type of ESBLs among the Enterobacteriaceae in Europe 
and Asia (Bonnet, 2004). A new variant of K. pneumo-
niae, designated as HV K. pneumoniae due to the high 
production of mucopolysaccharide was first described 
in 1986 by a Taiwanese doctors. The HV phenotype is 
also known as hvKP, and it enhances the biofilm pro-
duction and resistance to serum bactericidal activity. 
Biofilm is a complex polymer matrix composed of cells 
and matrix materials. The serum bactericidal activity is 
mediated by the complement proteins through the com-
plement pathway. The complement pathways lead, via 
the activation of C3, for the formation of the opsonin 
C3b, which finally results in the formation of the ter-
minal C5b-C9 complex and thus plays a key role in 
this defense system (Tomas et al., 1986). Many studies 
identified that hvKP strains produced more biofilm and 
are less susceptible to human serum than cKP strains 
(Li et al., 2014; Wu et al., 2011). Some studies have 
addressed that ESBL producing strain formed heavy 
biofilm than non-ESBL producing strains of K. pneu-
moniae (Yang and Zhang, 2008) and recently another 
study have been shown that the serum-resistant strains 
are significantly more general among ESBL-producing 
K. pneumoniae strains than among non-ESBL produc-
ers (Sahly et al., 2004). In view of previous findings, 
the goal of this study is to identify and correlate the 
various virulence genes, biofilm formation, bactericidal 
effect of serum and ESBL in between hvKP strain and 
cKP strain. To the best of our knowledge, the combine 
study of virulence genes, biofilm formation, bacteri-
cidal effect of serum and ESBL in between hvKP strain 
and cKP strain have not been previously reported.
Experimental
Materials and Methods
Bacterial strains and HV testing. A total of 96 
K. pneu moniae were isolated from sputum of pneu-
monic patients and were collected from a period of 
March 2013 to October 2014 in Shenyang Hospital 
of Liaoning Province and Tongliao Hospital of Nei 
Menggu province in China. K. pneumoniae strains 
were isolated from sputum that were identified and 
confirmed by standard methods (Farmer, 2003).
HV testing was done by string test. The string test 
was performed to distinguish hvKP from cKP strains. 
The string test was defined as the positive when the for-
mation of a mucoviscous string of > 5 mm was observed, 
by using a bacteriology inoculation loop to stretch a col-
ony that was grown overnight on an agar plate at 37°C. 
A positive string test with K. pneumoniae strains were 
designated as hvKP in Fig. 1 (Fang et al., 2004).
Antimicrobial susceptibility testing and ESBLs 
detection. Susceptibility testing for the 96 K. pneumo-
niae strains was carried out with disc diffusion methods. 
The control strains were used as Pseudomonas aerugi- 
nosa ATCC 27853, Staphylococcus aureus ATCC 29213, 
and Escherichia coli ATCC 25922. The interpretation 
of results were recorded according to the Clinical and 
Laboratory Standards Institute guidelines (CLSI, 2015). 
Antimicrobial agents tested included ampicillin, piper-
acillin, cefazolin, cefuroxime, cefoxitine, cefoperazon, 
ceftriaxone, cefotaxime, ceftazidime, cefepime, mero- 
penem, imipenem, aztreonam, amikacin, gentami- 
cin, trimethoprim-sulfamethoxazole, and ciprofloxa-
cin. These all antibiotics were purchased from Oxoid 
company, UK.
The combination-disk synergy tests using ceftazi-
dime (30 μg) ± clavulanic acid (10 μg) and cefotaxime 
(30 μg) ± clavulanic acid (10 μg) were performed to 
detect the phenotype of ESBLs for all the collected iso-
lates. The phenotype of ESBLs was confirmed by 5 mm 
or more increased zone diameter for the combination 
of clavulanic acid with either cefotaxime or ceftazidime 
versus its zone when tested alone. The ESBL negative 
Fig. 1. Positive string test (Mucoviscous string > 5 mm
on Agar plate).
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and positive strains were used as E. coli (ATCC 25922) 
and K. pneumoniae (ATCC 700603) respectively.
PCR for amplification of ESBL and virulence 
associated genes. The template DNA was prepared 
from bacterial colonies. The colonies of bacteria were 
picked and suspended in 100 μl of mili-Q water. The 
suspensions of sample were boiled for 15 min and rapid 
cool at –20°C for 5 min. The bacterial cell debris was 
separated by centrifugation for 10 min at 15,000 rpm 
and the supernatant was collected and used as a tem-
plate DNA. The DNA concentration was measured by 
using Epoch Gen5 CHS 2.01. The PCR specific primers 
and cycling condition used to detect the target gene are 
shown in Table  I and II respectively. The PCR prod-
uct from each of the detected genes was sequenced 
and compared with K. pneumonie DNA sequences on 
BLAST of NCBI (http://blast.ncbi.nlm.nih.gov/). Each 
of the target gene sequenced showed a high level of 
identification (> 98% homology) with the published tar-
get sequence (Gen Bank accession number: KF77780.1 
for mrkD; FJ483592.1 for fimH-1; AB355924.1 for 
magA (K1); AB362367.1 for wzy (K2); X17518.1 for 
FimH-1 F: ATG AAC GCC TGG TCC TTT GC R: GCT GAA CGC CTA TCC CCT GC 688
mrkD F: CCA CCA ACT ATT CCC TCG AA R: ATG GAA CCC ACA TCG ACA TT 240
magA (K1) F: GGT GCT CTT TAC ATC ATT GC R: GCA ATG GCC ATT TGC GTT AG  1 282
wzy (K2) F: GAC CCG ATA TTC ATA CTT GAC AGA G  R: CCT GAA GTA AAA TCG TAA ATA GAT GGC 641
rmpA F: ACT GGG CTA CCT CTG CTT CA R: CTT GCA TGA GCC ATC TTT CA 535
uge F: TCT TCA CGC CTT CCT TCA CT R: GAT CAT CCG GTC TCC CTG TA 534
kfu F: GAA GTG ACG CTG TTT CTG GC R: TTT CGT GTG GCC AGT GAC TC 797
aerobactin F: GCA TAG GCG GAT ACG AAC AT R: CAC AGG GCA ATT GCT TAC C T 556
TEM F: ATA AAA TTC TTG AAG ACG AAA R: GAC AGT TAC CAA TGC TTA ATC 1 080
SHV F: GGG TTA TTC TTA TTT GTC GC R: TTA GCG TTG CCA GTG CTC 930
CTX-M F: SCS ATG TGC AGY ACC AGT AA R: ACC AGA AYV AGC GGB GC 585
Table I
Primers used to detect the target gene sequences.
Target gene Sequences of Primer (5’-3’) Size of amplifiedproduct (bp)
FimH-1 95°C 4 min 95°C 1 min 57°C 1 min 72°C 1 min 72°C 10 min Repeated for 35 cycles
mrkD 95°C 4 min 95°C 45 sec 55°C 45 sec 72°C 45 sec 72°C 7 min Repeated for 30 cycles
magA (K1) 95°C 4 min 95°C 45 sec 59°C 45 sec 72°C 2 min 72°C 9 min Repeated for 30 cycles
wzy (K2) 95°C 4 min 95°C 45 sec 63°C 45 sec 72°C 1 min 72°C 9 min Repeated for 35 cycles
rmpA 95°C 4 min 95°C 45 sec 52°C 45 sec 72°C 1 min 72°C 7 min Repeated for 30 cycles
uge 95°C 4 min 95°C 45 sec 55°C 45 sec 72°C 1 min 72°C 7 min Repeated for 30 cycles
kfu 95°C 3 min 95°C 45 sec 59°C 45 sec 72°C 1 min 72°C 7 min Repeated for 35 cycles
aerobactin 95°C 5 min 95°C 1 min 54°C 1 min 72°C 1 min 72°C 7 min Repeated for 35 cycles
SHV 95°C 4 min 95°C 45 sec 56°C 45 sec 72°C 1 min 72°C 7 min Repeated for 35 cycles
TEM 94°C 4 min 94°C 45 sec 55°C 45 sec 72°C 1 min 72°C 7 min Repeated for 35 cycles
CTX-M 95°C 4 min 95°C 45 sec 58°C 45 sec 72°C 1min 72°C 7 min Repeated for 35 cycles
Table II
Cycling condition for PCR.
Target gene Cycling Conditions
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rmpA; 633804.1 for uge; KJ633800.1 for kfu; X98099.1 
for SHV, HM131427.1 for TEM; HQ214044.1 for 
CTX-M). These genes were chosen as the positive con-
trol for the consequent PCR experiments.
Serum bactericidal assays. Normal human serum 
was obtained from the healthy adult volunteers. The sera 
were stored as aliquots at –70°C. K. pneumonia strains 
were determined by an established method (Podschun 
et al., 1993). An inoculum of 2.5 × 104 CFU, prepared 
from the mid-log phase, was mixed at a 1:3 vol/vol ratio 
with normal human serum. The final mixture, com-
prising 75% serum by volume, was incubated at 37°C 
for 3 hours, and 100 µl from each well was taken out 
for CFU determination before and after incubation at 
37°C. The rate of survival was expressed as the number 
of viable bacteria treated with serum compared to the 
number of pretreatment. The assay was performed in 
triplicate and repeated three times.
Interpretation of results: following the criteria used 
by Benge (1988). The isolates were regarded as serum 
sensitive if at 3 h the viable counts were reduced to < 1% 
of the initial counts and resistant if > 90% of the organ-
isms were still viable. Isolates having survival rates of 
1–90% were regarded as intermediate sensitive.
Biofilm formation assays. Microtiter plate method 
was carried out according to Stepanovic et al. (2007) 
with a few modifications. Briefly, K. pneumoniae strains 
were grown overnight at 37°C in Mueller Hinton broth. 
The culture was adjusted to 0.5 McFarland then diluted 
1:100 in the Mueller Hinton broth. Three wells of a ster-
ile 48-well plastic tissue culture plate with a  lid were 
filled with 1000 µl of diluted bacterial culture each. 
The negative control wells contained MH broth only. 
The plates were covered and incubated at 37°C for 
24 h. The content of each well was aspirated, and was 
washed three times with normal saline (to remove free-
floating ‘‘planktonic’’ bacteria). Biofilms formed by bac-
teria adherent ‘‘sessile’’ to the wells were heat-fixed by 
exposing them to hot air at 60°C for 3 hours and stained 
with 0.5% of Crystal Violet for 15 min. Excess stain was 
rinsed off with running tap water and the plates were 
dried. To quantify biofilm biomass, the crystal violet 
dye bound to the adherent cells was dissolved by adding 
1000 µl of 33% acetic acid solution to each well and after 
10 min, the OD of each well was measured at 595 nm. 
Each assay was performed in triplicate and repeated 
at least three times. 
The interpretation of biofilm formation was done 
according to the criteria of Stepanovic et al. (2007).
Interpretation of biofilm formation results
Average OD value Biofilm production
≤ ODc / ODc < ~ ≤ 2x ODc Non/weak
2x ODc < ~ ≤ 4x ODc Moderate
> 4x ODc Strong
Note: ODc = average OD of negative control + 3x stan- 
dard deviation of negative control optical density 
cut-off value (ODc)
Statistical analysis. The statistical analyses were 
performed using Statistical Package for Social Science 
21.0. The descriptive data were reported as mean ± SD 
and percentage. The normally distribution of the data 
was performed by Kolmogorov-Smirnov test. For the 
differences in the outcomes between various groups, 
categorical variables were compared using chi-square 
analysis. When the number of cases was smaller than 5, 
the Fisher’s exact test was used. The P value < 0.05 was 
defined as a significance.
Ethics statement. For collection of normal human 
serum from healthy adult volunteers and sputum from 
pneumonic patients, the method and the respective 
consent of documents were approved by the Ethics 
Committee of the Norman Bethune Health Science 
Center, Jilin University, China. The written informed 
consent is provided by all volunteers.
Results
Bacterial strains and HV of K. pneumoniae strains. 
The samples were collected from March 2013 to October 
2014, and a total of 96 patients were diagnosed as suffer-
ing pneumonia with the culture-positive K. pneumoniae. 
Out of them, 71 (74.0%) were males and 25 (26.0%) 
were females. The mean age was 64.8 ± 15.4  years. 
Based on the results of the modified string test HV phe-
notypes were identified in 39 (40.6%) of the 96 isolates. 
The isolation of cKP and hvKP strains were obtained 
as 57 (59.4%) and 39 (40.6%), respectively. A signifi-
cantly higher number of patients with cKP (P = 0.009) 
was detected. Neither age nor sex was associated with 
positive string test (both P > 0.05).
Antimicrobial resistance and ESBL. The number 
of cKP strains exhibiting resistance to the tested anti-
microbials was significantly higher than that of the 
hvKP strains, with the exception of ampicillin, pipera-
cillin, cefuroxime, cefoxitine, cefoperazone, imopenem, 
meropenem and ciprofloxacin, shown in Table  III. 
The results of the combined disk test confirmed that 
37  (38.5%) isolates were ESBL-producing strains. 
ESBL were identified in more number of cKP strains 
(28/57 [49.1%]) than in hvKP strains (11/39 [28.2%]) 
(P = 0.040). These results indicate a significant negative 
association between the ESBL producer and the HV 
phenotype in these isolates. In addition, single and mul-
tiple types of ESBL genes were present in cKP strains, 
whereas, only single gene was present in hvKP strains, 
shown in Table IV.
Virulence genetic characteristics of K. pneumo­
niae. The pneumonia is caused by K. pneumoniae strains 
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that were encoded following percentage of virulence 
genes as FIM-H 85 (88.5%), mrkD 80 (83.4%), magA 
22 (22.9%), K2 25 (26.0%), rmpA 62 (64.6%), uge 74 
(77.0%), kfu 33 (34.3%), and aerobactin 63 (65.6%).
Virulence genetic characteristics of hvKP vs cKP. 
The prevalence of K1 and K2 gene in hvKP isolates was 
significantly increased (P = 0.024 and P = 0.039, respec-
tively), than that in cKP isolates. Moreover, hvKP strains 
were strongly associated with rmpA (P < 0.001), than 
cKP strains. In addition, uge, kfu and aerobactin were 
also strongly associated with hvKP strains (P = 0.015, 
P = 0.014 and P = 0.001, respectively) than cKP strains. 
However, no significant difference was found in FIM-1 
and mrkD3 genes (P = 0.107 and P = 0.403, respectively) 
in between hvKP and cKP strains .
Biofilm and serum resistance characteristics of 
cKP vs ESBL producing cKP strains . ESBL produc-
ing cKP strains were highly associated with strong 
biofilm formation (P < 0.001) than cKP strains. But no 
significant difference (P = 0.208) was found with mod-
erate biofilm formation in between ESBL producing 
cKP strains and cKP strains. In the serum bactericidal 
test, similar results were found as biofilm formation 
that ESBL producing cKP strains were significantly 
asso ciated with serum resistance (P < 0.001) than cKP 
strains and no significant difference was found with 
intermediate sensitive results (P = 0.490) in Table V.
Biofilm and serum resistance characteristics of 
cKP vs hvKP strains. The hvKP strains were signifi-
cantly more increased association with moderate and 
strong biofilm formation (P < 0.001 and P = 0.039 
respectively) than cKP strains. In addition, the hvKP 
strains were also more associated with intermediate 
sensitive and resistance of the serum bactericidal test 
(P = 0.002 and P = 0.004 respectively) than cKP strains 
in Table VI.
Biofilm and serum resistance characteristics of 
ESBL producing cKP vs hvKP strains. The hvKP strains 
were only significantly more associated with moderate 
biofilm formation and intermediate sensitive of serum 
bactericidal test (P = 0.005 and P = 0.016 respectively) 
than ESBL producing cKP strains. Whereas, no signifi-
cant difference was found with strong biofilm formation 
(P = 0.105) and with serum resistance (P = 0.420) of 
serum bactericidal test in between ESBL producing 
cKP strains and hvKP strains, Table VII. Biofilm and 
serum resistance characteristics of ESBL producing 
cKP vs ESBL producing hvKP strains. No significant 
Ampicillin 51 (89.5) 37 (94.9) 0.347
Pipracillin 27 (47.4) 14 (35.9) 0.264
Cefazolin 33 (57.9) 10 (25.6) 0.002*
Cefuroxime 31 (54.4) 15 (38.5) 0.125
Cefoxitin 14 (24.6)  6 (15.4) 0.277
Cefoperazon 12 (21.1)  4 (10.3) 0.163
Ceftriaxone 31 (54.4)  8 (20.5) 0.001*
Cefotaxime 28 (49.1)  9 (23.1) 0.010*
Ceftazidime 23 (40.4)  7 (17.9) 0.020*
Cefepime 24 (42.1)  2 (5.1) 0.001*
Aztreonam 25 (43.9)  4 (10.4) 0.001*
Imipenem  3 (5.3)  1 (2.6) 0.644
Meropenem  4 (7.0)  0 (0) 0.144
Amikacin 18 (31.6)  2 (5.1) 0.002*
Gentamycin 26 (45.6) 10 (25.6) 0.047*
Trimethoprim-
sulfamethoxazole 28 (49.1)  8 (20.5) 0 .004*
Ciprofloxacin 15 (26.3)  9 (23.1) 0.719
ESBL total 28 (49.1%) 11 (28.2%) 0 .040*
Table III
The percentage of antimicrobial resistance of cKP strain
and hvKP strain.
* P < 0.05 is significant
cKP (n = 57)
No. (%)
hvKP (n = 39)
No. (%) P – value
TEM  1 (3.6%) 2 (18.2%)
SHV  6 (21.4%) 5 (45.4%)
CTX-M  4 (14.3%) 4 (36.3%)
TEM+SHV  1 (3.6%) –
TEM+CTX-M 11 (39.3%) –
SHV+CTX-M  1 (3.6%) –
TEM+SHV+CTX-M  4 (14.3%) –
Table IV




of strains = 28)
No. of strains (%)
hvKP (Total no.
of strains = 11)
No. of strains (%)
Biofilm formation:
Non** 21 (72.4%)  4 (14.3%) 0.001*
Moderate  2 (6.9%)  5 (17.9%) 0.208
Strong  6 (20.7%) 19 (67.9%) 0.001*
Serum Res. test:
Sensitive 21 (72.4%)  6 (21.4%) 0.001*
Intermediate sensitive  6 (20.7%)   8 (28.6%) 0.490
Resistance  2 (6.9%) 14 (50%) 0.001*
Table V
The comparision of biofilm and serum resistance in between
cKP and ESBL producing cKP strains.
** Non and weak biofilm formation is kept
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difference was found in either biofilm formation or bac-
tericidal effect of serum in between ESBL producing 
cKP and ESBL producing hvKP strains (both P > 0.05) 
in Table VIII.
Discussion
Although K. pneumoniae is known to be a common 
pathogen responsible for community and hospital-
acquired pneumonia as well as blood and urinary tract 
infections (Lin et al., 2010; Podschun and Ullmann, 
1998). Our data demonstrated a negative associa-
tion between pneumonia and hvKP (P = 0.009). This 
implies that cKP strains predominantly are associated 
with respiratory infections. These data are consistent 
with previous reports (Li et al., 2014). In this study, we 
compared the drug resistance and ESBL characteris-
tics of hvKP and cKP isolates. Previous studies have 
indicated that hvKP strains are stronger resistant to 
antibiotics than cKP strains, whereas more recent stud-
ies have not only indicated that such strains are less 
associated with antibiotic resistance (Li et al., 2014), 
but also shown that ESBL were significantly lesser than 
cKP strains (Su et al., 2008). Consequently, these data 
are inconclusive. In the present study, hvKP strains 
were shown less resistant than cKP strains, for 10 out 
of 17 antimicrobial drugs tested. Moreover, ESBL were 
shown a negative association with hvKP (P = 0.40). In 
addition, the cKP strains possessed one to three types 
of ESBL gene but hvKP strains have only one type. The 
reason for this difference remains unknown. It can be 
speculated that hvKP strains cannot acquire resistance-
related plasmids, or that some drug-resistant genes are 
lost when they become hypervirulent (Li et al., 2014).
Virulence genetic characteristics of hvKP vs cKP show 
That the hvKP was more virulent in a model of subcu-
taneous abscess of rat than cKP (Pomakova et al., 2012). 
Serotype K1 and K2 of K. pneumoniae cause pyogenic 
liver abscess and is also repeatedly reported in commu-
nity acquired pneumonia (Decre et al., 2011). The kfu 
which mediates uptake of ferric iron, is more common 
in hvKP compared with cKP strains and was shown to 
be a  virulence factor in mice after IG (intragestinal) 
but not after IP (intraperitonium) (Ko et al., 2002). 
Aerobactin production was more common in hvKP 
strains than cKP strains, which was demonstrated by 
a cross-feeding assay (Yu et al., 2007). This analysis sug-
gested that the hvKP strains might have the capability to 
acquire iron more readily than the cKP strains. 
In this study, we found that the prevalence of viru-
lence associated genes viz., K1, K2, rmpA, uge, kfu and 
aerobactin were strongly associated with hvKP than 
cKP strains. There was no any significant difference 
of FIM-1, mrkD genes between both. These data are 
consistent with previous reports, which describe an 
association between K1 and K2 expression and asso-
ciated with rmpA in between hvKP and cKP strains 
(Li et al., 2014). Also an agreement with some another 
studies suggested that the K1 and K2 capsular genes 
are common in hvKP strains, cKP strains may also pos-
Biofilm Formation: Non**  4 (13.4%)  0 (0%) 0.111
Moderate  5 (17.9%) 15 (53.6%) 0.005*
Strong 19 (67.9%) 13 (46.4%) 0.105
Serum Res. Test : Sensitive  6 (21.4%)  0 (0%) 0.023*
Intermediate sensitive  8 (28.6%) 17 (60.7%) 0.016*
Resistance 14 (50%) 11 (39.3%) 0.420
Table VII
The comparison of biofilm and serum resistance between
ESBL producing cKP and hvKP strains.
** Non and weak biofilm formation is kept










Biofilm formation: Non**  4 (14.3%) 0 (0%) 0.309
Moderate  5 (17.9%) 5 (45.5%) 0.080
Strong 19 (67.9%) 6 (54.5%) 0.435
Serum Res. test: Sensitive  6 (21.4%) 0 (0%) 0.158
Intermediate Sensitive  8 (28.6%) 6 (54.5%) 0.128
Resistance 14 (50%) 5 (45.5%) 0.798
Table VIII
The comparison of biofilm and serum resistance between
ESBL producing cKP and ESBL producing hvKP strains.
** Non and weak biofilm formation is kept











Biofilm Formation: Non** 21 (72.4%)  0 (0%) 0.001*
Moderate  2 (6.9%) 15 (53.6) 0.001*
Strong  6 (20.7%) 13 (46.4%) 0.039*
Serum Res. test: Sensitive 21 (72.4%)  0 (0%) 0.001*
Intermediate sensitive  6 (20.7%) 17 (60.7%) 0.002*
Resistance  2 (6.9%) 11 (39.3%) 0.004*
Table VI
The comparison of biofilm and serum resistance between 
cKP and hvKP strains.
** Non and weak biofilm formation was kept
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sess these genes (Brisse et al., 2009) and hvKP strains 
may have a non-K1/K2 genes (Fang et al., 2007). Some 
studies have considered the sources of the specimen 
and found that the proportion of ESBL-producing 
strains in the isolates from sputum and urine except 
blood and wound was significantly higher in biofilm-
forming strains than in non-biofilm-forming strains 
(Watnick and Kolter, 2000; Yang and Zhang, 2008). In 
the present study, we showed that the ESBL producing 
isolated strains had a more ability to form biofilm in 
comparison with non ESBL producing strains in the 
source of sputum specimen. It may be due to: (i) the 
biofilm is a multispecies microbial community and 
these species can share at a high rate of their genetic 
material (ii) the ESBLs can be induced by low concen-
tration of antibiotic, which is a cause of decrease pen-
etration into biofilm (Wacharotayankun et al., 1993; 
Yang and Zhang, 2008). Another recent study identified 
that the hvKP strain produces higher biofilm than cKP 
strains (Wacharotayankun et al., 1993). Even our study 
showed similar correlation between hvKP strain and 
cKP strain, and it has been suggested that this ability 
increases colonization. Studies have shown that serum-
resistant strains are significantly more increased among 
ESBL-producing K. pneumoniae strains than among 
non-ESBL producer strains (Sahly et al., 2004) and 
hvKP strains are more resistant to serum than com-
pared with cKP strains (Wacharotayankun et al., 1993). 
We investigated a relationship between ESBL produc-
tion and the serum resistance of hvKP strains and cKP 
strains. The ESBL-producing K. pneumoniae strains 
showed significantly more resistant to the serum bac-
tericidal effect than their non-ESBL-producing strains. 
Moreover, hvKP strains were shown significantly high 
resistant to the serum bactericidal effect than compared 
with cKP strains. However, no any significant difference 
was found in between ESBL producing cKP strains and 
ESBL producing hvKP strains. It has been suggested 
that (I) the production of R-plasmid-coded ESBLs are 
increased when associated with adhesive (Darfeuille-
Michaud et al., 1992), (ii) and the increase produc-
tion of extra-capsular polysaccharide of hvKP strains 
(Wacharotayankun et al., 1993).
Conclusion
The hvKP strains produce increased biofilm, less 
susceptible to serum and possess more virulence gene 
compared with cKP strains. Whereas, the ESBL pro- 
ducing cKP strains didn’t show any significant differ-
ence between biofilm formation and bactericidal effect 
of serum compared with hvKP strains and ESBL pro- 
ducing hvKP strains. Thus hvKP strains and ESBL 
producing cKP strains are highly pathogenic to com-
pare cKP strains.
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